Should we use psychostimulant drugs to boost the emergence from general anesthesia?

Anesthesiology

Volumn 117, Issue 6, 2012, Pages 1393-1394

  Petrenko, Andrey B ^a   Takamatsu, Misako ^b   Baba, Hiroshi ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GABAERGIC RECEPTOR AFFECTING AGENT; METHYLPHENIDATE; NORADRENALIN; PROPOFOL; PSYCHOSTIMULANT AGENT;

AGITATION; ALERTNESS; ANESTHETIC RECOVERY; BASAL GANGLION; BRAIN FUNCTION; COGNITIVE DEFECT; CONSCIOUSNESS LEVEL; DELIRIUM; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; ELECTROENCEPHALOGRAM; GENERAL ANESTHESIA; HUMAN; LETTER; LOCOMOTION; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESTLESSNESS; RIGHTING REFLEX; SOMNOLENCE;

ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; METHYLPHENIDATE; PROPOFOL;

EID: 84870203086     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318272d898     Document Type: Letter

References (14)

1. Chemali JJ, Van Dort CJ, Brown EN, Solt K: Active emergence from propofol general anesthesia is induced by methylphenidate. Anesthesiology 2012; 116:998-1005
2. Sanders RD, Tononi G, Laureys S, Sleigh JW: Unresponsiveness ≠ unconsciousness. Anesthesiology 2012; 116:946-59
3. Sanders RD: Hypothesis for the pathophysiology of delirium: Role of baseline brain network connectivity and changes in inhibitory tone. Med Hypotheses 2011; 77:140-3
4. Coull JT, Büchel C, Friston KJ, Frith CD: Noradrenergically mediated plasticity in a human attentional neuronal network. Neuroimage 1999; 10:705-15
5. Groenewegen HJ: The basal ganglia and motor control. Neural Plast 2003; 10:107-20
6. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006; 60:1111-20
7. Borycz J, Zapata A, Quiroz C, Volkow ND, Ferré S: 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. Neuropsychopharmacology 2008; 33:619-26
8. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW: Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002; 27:699-711
9. Volz TJ, Farnsworth SJ, Rowley SD, Hanson GR, Fleckenstein AE: Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: The role of muscarinic and dopamine D2 receptors. J Pharmacol Exp Ther 2008; 327:161-7
10. Ikeda H, Hayashi M: The effect of self-awakening from nocturnal sleep on sleep inertia. Biol Psychol 2010; 83:15-9
11. Yang PB, Swann AC, Dafny N: Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats. Behav Brain Funct 2006; 2:3
12. Yang PB, Swann AC, Dafny N: Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res 2006; 1073-1074:164-74
13. Edgar DM, Seidel WF: Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther 1997; 283:757-69
14. Gruner JA, Marcy VR, Lin YG, Bozyczko-Coyne D, Marino MJ, Gasior M: The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents. Sleep 2009; 32:1425-38